Skip to main content

Month: May 2025

After Strong Quarter, Radware Announces U.S. Expansion

Adds seasoned security leadership, dozens of new hires, new tech alliances; reinforces commitment to AI innovation MAHWAH, N.J., May 07, 2025 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, is executing an aggressive strategy to expand its market presence and accelerate growth across its cloud services business in the U.S. The company is making strategic new hires, adding tech alliances, and reinforcing its commitment to AI innovation. The announcement follows Radware’s report on its strong first quarter financial results. “Increasing business opportunities have led us to fast track an aggressive U.S. growth plan,” said Roy Zisapel, Radware’s president and chief executive officer. “We are doubling down our efforts in the region. This includes...

Continue reading

Taboola Reports Strong Q1 2025 Financial Results; Results Above High-End of Guidance Across All Key Metrics

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the first quarter ended March 31, 2025. “We’re pleased to start the year off strong, coming in above our guidance across all key metrics,” said Adam Singolda, CEO of Taboola. “We’re building real momentum — fueled by disciplined execution, traction on our Realize platform, and a deep belief in our long-term opportunity. We’ll continue to invest where we see growth, return capital through share repurchases, and stay focused on becoming the leader in performance advertising beyond search and social.” First Quarter 2025 Financial Results(All comparisons are to the first quarter of 2024 unless otherwise noted.)Revenues of $427 million, an increase of 3%. Revenues were...

Continue reading

Stella-Jones Announces First Quarter Results

2023-2025 financial objectives remain unchangedSales of $773 million, relatively unchanged from Q1 2024 Operating income of $143 million, including insurance settlement of $38 million Strong EBITDA(1) of $179 million, or 23.2% margin(1), including 5% from insurance settlement Robust available liquidity of $691 million at quarter-end Acquisition post-quarter of a steel transmission structure manufacturer, aligned with strategy to support North American infrastructureMONTREAL, May 07, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced financial results for its first quarter ended March 31, 2025. “We delivered a strong EBITDA margin in the first quarter, reflecting the resilience and strength of our business through softer volumes,” said Eric Vachon, President and Chief Executive...

Continue reading

Barrick Reports Share Repurchases and Declares Q1 Dividend

All amounts expressed in US dollars TORONTO, May 07, 2025 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:GOLD1)(TSX:ABX) (“Barrick” or the “Company”) today announced the declaration of a dividend of $0.10 per share for the first quarter of 2025. The dividend is consistent with the Company’s Performance Dividend Policy announced at the start of 2022. The Q1 2025 dividend will be paid on June 16, 2025 to shareholders of record at the close of business on May 30, 2025. In addition to the quarterly dividend, Barrick repurchased approximately 7.69 million shares during Q1 under the share buyback program that was announced in February 2025. “Our operating performance and growing margins have allowed us to provide significant returns to shareholders during the quarter through the combination of dividends and share buybacks at a compelling...

Continue reading

Magnera Reports Second Quarter Results – Provides Updated Outlook

Second Quarter HighlightsGAAP: Net sales of $824 million, Operating income of $4 million Non-GAAP: Adjusted EBITDA of $89 million, Post-merger adjusted free cash flow $42 million Reaffirming post-merger adjusted free cash flow range & lowering full year comparable Adjusted EBITDA rangeCHARLOTTE, N.C., May 07, 2025 (GLOBE NEWSWIRE) —  Magnera (NYSE: MAGN), a global leader in specialty materials for the consumer products and personal care markets, today reported financial results for its fiscal 2025 second quarter ended March 29, 2025. Curt Begle, Magnera’s CEO, commented: “This quarter underscores the resilience of our business as we navigate ongoing global economic uncertainty. Our team has transitioned from stabilizing the business through a disciplined integration plan to actively executing on identified optimization...

Continue reading

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) —  Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the anticipated impact of potential tariffs on imported pharmaceuticals to the United States. Alvotech expects that potential U.S. tariffs on imported pharmaceuticals should have minimal impact on the Company’s product revenues in 2025. Alvotech manufactures its biosimilars in Iceland, a country which currently faces the minimum tariff of 10% on goods imported to the U.S. A 10% tariff on pharmaceuticals would raise the cost of biosimilars from Alvotech imported to the U.S. for customers by less than 1% of Alvotech’s expected total product revenues in 2025. Furthermore, according to contracted...

Continue reading

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the anticipated impact of potential tariffs on imported pharmaceuticals to the United States. Alvotech expects that potential U.S. tariffs on imported pharmaceuticals should have minimal impact on the Company’s product revenues in 2025. Alvotech manufactures its biosimilars in Iceland, a country which currently faces the minimum tariff of 10% on goods imported to the U.S. A 10% tariff on pharmaceuticals would raise the cost of biosimilars from Alvotech imported to the U.S. for customers by less than 1% of Alvotech’s expected total product revenues in 2025. Furthermore, according to contracted terms, customers are responsible for all costs of transport...

Continue reading

Nokia Corporation – Managers’ transactions (Ihamuotila)

Nokia CorporationManagers’ transactions7 May 2025 at 12:20 EEST Nokia Corporation – Managers’ transactions (Ihamuotila) Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Ihamuotila, Timo Position: Member of the Board Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06 Notification type: INITIAL NOTIFICATIONReference number: 107170/7/8 ____________________________________________Transaction date: 2025-05-06Venue: AQEDInstrument type: SHAREISIN: FI0009000681Nature of transaction: ACQUISITION Transaction details(1): Volume: 1512 Unit price: 4.4025 EUR Aggregated transactions (1): Volume: 1512 Volume weighted average price: 4.4025 EUR____________________________________________Transaction date: 2025-05-06Venue:...

Continue reading

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Madrid, Spain.– May 7, 2025 – Technology company Lleida.net (BME: LLN) (EPA: ALLN) (OTCQX: LLEIF) received a new research report from Checkpoint Partners, maintaining its ‘Buy’ rating and setting a price target of €4 per share. The report, written by analyst Guillermo Serrano, cites Lleida.net’s strong financial recovery, including a 477% increase in profit before tax and a 129% rise in EBITDA YoY during the first quarter of 2025, driven by growth in SaaS and Commercial SMS business lines. According to Serrano, “We are raising our 12-18-month price target to €4.00 (vs €3.00), which would place the stock at a 2026 EV/EBITDA (cash) multiple of 14x. Our target multiple remains unchanged; the increase is solely driven by our increased EBITDA estimates.” The report notes that Lleida.net is currently trading at...

Continue reading

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2025

Press ReleaseVELIZY-VILLACOUBLAY, France — May 7, 2025                 Declaration of the number of outstanding shares and voting rights as of April 30, 2025 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of April 30, 2025, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,340,781,968 Number of voting rights*: 2,013,969,163 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.